PLX-4720

N/A

Report date: 2022/05/25 11:16:45
NME

Base Information

Drug NamePLX-4720
Drug Alias NamePLX-4720
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitorsB-raf V600E inhibitors
TargetsSerine/threonine-protein kinase B-rafB-raf V600E
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPlexxikon IncDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCharité – Universitätsmedizin Berlin
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A